Product Information

ACITRETIN 17.5 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $4.5546 per EA under NDC 00115175108. Its NADAC has been published 105 times since Nov 20, 2024.

FDA first approved this application on Dec 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACITRETIN 17.5 MG CAPSULE

Acitretin
$4.5546per EA

Strength

17.5 mg/1

NDC

00115175108

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ACITRETIN

Approval Type

Generic (ANDA)

FDA Application

ANDA202552

FDA Approved

12/23/2015

TE Code

AB

On Market Since

1/4/2016

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ACITRETIN 17.5 MG CAPSULE has been published 105 times since Nov 20, 2024, and over the history we have for it it has declined 65.5%. The table below summarizes its recorded NADAC range and movement.

Current price$4.5546 per EA
All-time high$13.2128 (Dec 11, 2024)
All-time low$4.4994 (Oct 21, 2026)
52-week high$7.9486
52-week low$4.4994
Median price$6.3673
Average price$7.2742
Largest weekly change+55.6% (Jan 21, 2026)
Weeks tracked105
Tracking sinceNov 20, 2024

Price History

1W

+1.2%

1M

+0.8%

3M

-0.6%

6M

-28.5%

1Y

-10.8%

3Y

N/A

5Y

N/A

All

-65.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACITRETIN 17.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ACITRETIN 17.5 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $4.5546 per EA (NDC 00115175108), effective Nov 18, 2026.

How has the price of ACITRETIN 17.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ACITRETIN 17.5 MG CAPSULE has declined 65.5%. It has been tracked across 105 weekly CMS publications since Nov 20, 2024.

What are the highest and lowest recorded NADAC prices for ACITRETIN 17.5 MG CAPSULE?

Since Nov 20, 2024, the NADAC for ACITRETIN 17.5 MG CAPSULE has ranged from a low of $4.4994 (Oct 21, 2026) to a high of $13.2128 (Dec 11, 2024), with a median of $6.3673 per EA.

Are there cheaper alternatives to ACITRETIN 17.5 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACITRETIN 17.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures ACITRETIN 17.5 MG CAPSULE?

ACITRETIN 17.5 MG CAPSULE (NDC 00115175108) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.